Dr. Machteld N. Hylkema is an Associate Professor at the Department of Pathology and Medical Biology at University Medical Center Groningen (UMCG). She earned her Master’s in Biology at the University of Leiden in 1991 and PhD at the University of Amsterdam in 1995. That same year, she moved to Groningen for a postdoctoral position in the Department of Cell Biology and Histology, University of Groningen. In 1998, she pursued postdoctoral research at Stanford University. She continued her postdoctoral work in the Department of Pathology and Medical Biology, UMCG and was promoted to Assistant Professor in 2003. In 2014, she was appointed Associate Professor. She has a broad research interest in the early life origins and pathogenesis of obstructive lung diseases and developed experimental mouse models to study the effects of maternal smoking during pregnancy on prenatal programming and susceptibility to asthma and COPD. Her current research focuses on the abnormal behavior of lung progenitor/stem cells that contributes to emphysema progression and impaired lung tissue repair in COPD. She has secured over EUR 2.5 million in research grants from national and European agencies, and from pharmaceutical companies. She is a member of the review panel of the Swedish Research Council. Since March 2018, she has served as the Academic Director of the Erasmus+ International Master in Innovative Medicine program, for which she and her consortium secured EU grants in 2015, 2019, and 2024.
Dr. Machteld N. Hylkema is an Associate Professor at the Department of Pathology and Medical Biology at University Medical Center Groningen (UMCG). She earned her Master’s in Biology at the University of Leiden in 1991 and PhD at the University of Amsterdam in 1995. That same year, she moved to Groningen for a postdoctoral position in the Department of Cell Biology and Histology, University of Groningen. In 1998, she pursued postdoctoral research at Stanford University. She continued her postdoctoral work in the Department of Pathology and Medical Biology, UMCG and was promoted to Assistant Professor in 2003. In 2014, she was appointed Associate Professor. She has a broad research interest in the early life origins and pathogenesis of obstructive lung diseases and developed experimental mouse models to study the effects of maternal smoking during pregnancy on prenatal programming and susceptibility to asthma and COPD. Her current research focuses on the abnormal behavior of lung progenitor/stem cells that contributes to emphysema progression and impaired lung tissue repair in COPD. She has secured over EUR 2.5 million in research grants from national and European agencies, and from pharmaceutical companies. She is a member of the review panel of the Swedish Research Council. Since March 2018, she has served as the Academic Director of the Erasmus+ International Master in Innovative Medicine program, for which she and her consortium secured EU grants in 2015, 2019, and 2024.